(b) Pedgaonkar G. S., Sridevi J. P., Jeankumar V. U., Saxena S., Devi P. B., Renuka J., Yogeeswari P., Sriram D.,
Development Of Benzo[D]Oxazol-2(3H)-Ones Derivatives as Novel Inhibitors of Mycobacterium Tuberculosis Inha,
Bioorganic Med. Chem.,
22: 6134-6145 (2014);
(c) Bach A., Pizzirani D., Realini N., Vozella V., Russo D., Penna I., Melzig L., Scarpelli R., Piomelli D.,
Benzoxazolone Carboxamides as Potent Acid Ceramidase Inhibitors: Synthesis and Structure–Activity Relationship (SAR) Studies,
J. Med. Chem.,
58: 9258-9272 (2015);
(d) Giles M. E., Thomson C., Eyley S. C., Cole A. J., Goodwin C. J., Hurved P. A., Morlin A. J., Tornos J., Atkinson S., Just, C.,
Development of a Manufacturing Process for Sibenadet Hydrochloride, the Active Ingredient of Viozan,
Org. Process. Res. Dev.,
8: 628-642 (2004);
(e) Borsini F., Evans K., Jason K., Rohde F., Alexander B., Pollentier S.,
Pharmacology of Flibanserin,
CNS Drug Rev.,
8: 117-142 (2002);
[10] Weng J. Q., Liu X. H., Huang H., Tan C. X., Chen J.,
Synthesis, Structure and Antifungal Activity of New 3-[(5-Aryl-1,3,4-Oxadiazol-2-Yl)Methyl]Benzo[D]Thiazol-2(3H)-Ones,
Molecules.,
17: 989-1001 (2012).
(g) Abdoli M., Angeli A., Bozdag M., Carta F., Kakanejadifard A., Saeidian H., Supuran C. T.,
Synthesis and Carbonic Anhydrase I, II, VII, and IX Inhibition Studies with a Series of Benzo [D] Thiazole-5-and 6-Sulfonamides,
J. Enzyme. Inhib. Med. Chem.,
32: 1071-1078 (2017);
(h) Saeidian H., Sadighian H., Abdoli M., Sahandi M.,
Versatile and Green Synthesis, Spectroscopic Characterizations, Crystal Structure and DFT Calculations of 1,2,3‒Triazole‒Based Sulfonamides,
J. Mol. Struct.,
1131: 73-78 (2017);